Dentsply Sirona (XRAY) Cash from Financing Activities (2009 - 2026)
Dentsply Sirona (XRAY) reported Cash from Financing Activities of -$119.0 million for Q1 2026, down 196.75% on a YoY basis from $123.0 million in Q1 2025, and down 20.2% quarter-over-quarter from -$99.0 million in Q4 2025.
Dentsply Sirona (XRAY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Dentsply Sirona has reported Cash from Financing Activities for 18 years, with the latest figure at -$119.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 196.75% year-over-year to -$119.0 million; the trailing twelve-month figure through Mar 2026 stood at -$322.0 million (down 95.15% YoY), and the FY2025 full-year result was -$80.0 million, up 73.51% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$119.0 million, down from -$99.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $123.0 million in Q1 2025, with the low at -$171.0 million in Q2 2024.
- Historically, Cash from Financing Activities has averaged -$66.9 million across 5 years, with a median of -$79.0 million in 2024.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities plunged 1716.67% — and 2025, when it jumped 978.57%.
- Dentsply Sirona's Cash from Financing Activities stood at -$161.0 million in 2022, then rose by 20.5% to -$128.0 million in 2023, then soared by 70.31% to -$38.0 million in 2024, then slumped by 160.53% to -$99.0 million in 2025, then fell by 20.2% to -$119.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$119.0 million (Q1 2026), -$99.0 million (Q4 2025), and -$36.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Dentsply Sirona | 2.09 Bn | 1.90 Bn | 427.00 Mn | -119.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -119.00 Mn |
| Mar 31, 2026 | -119.00 Mn |
| Dec 31, 2025 | -99.00 Mn |
| Dec 31, 2025 | -99.00 Mn |
| Sep 30, 2025 | -36.00 Mn |
| Sep 30, 2025 | -36.00 Mn |
| Jun 30, 2025 | -68.00 Mn |
| Jun 30, 2025 | -68.00 Mn |
| Mar 31, 2025 | 123.00 Mn |
| Mar 31, 2025 | 123.00 Mn |
| Dec 31, 2024 | -38.00 Mn |
| Dec 31, 2024 | -38.00 Mn |
| Sep 30, 2024 | -79.00 Mn |
| Sep 30, 2024 | -79.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Dec 31, 2023 | -128.00 Mn |
| Dec 31, 2023 | -128.00 Mn |